← Return to Circulating tumor cells to determine risk of recurrence

Discussion

Circulating tumor cells to determine risk of recurrence

Breast Cancer | Last Active: Sep 20 3:40pm | Replies (41)

Comment receiving replies
@windyshores

Yes no benefit but "high risk." They have since changed that label because mine was 5.7% which Oncotype classifies as low! My Oncotype risk was 6%.

I also did the Prosigna Assay at the 5 year point which had my risk closer to 9%.

My pathology had a lot of contradictions and posed a lot of concerns so at 5 years I wanted to do both tests. They used my post-surgical specimens from 5 years earlier.

Jump to this post


Replies to "Yes no benefit but "high risk." They have since changed that label because mine was 5.7%..."

I haven't heard of the Prosigna Assay but will write that down. I am at the beginning of my Letrozole journey. My Oncotype was 7%.